Jane McLelland

How have patient advocacy groups and clinics promoted fenbendazole and ivermectin for cancer, and what conflicts or incentives shape those narratives?

Patient advocacy communities and a small but vocal set of clinics have amplified interest in repurposing through testimony-driven social media groups, celebrity mentions, patient-focused platforms, an...